Today: 27 April 2026
Browse Category

NASDAQ:USEG 27 April 2026

U.S. Energy Corp Stock Jumps as $285 Helium Deal Gives Big Sky a Buyer

U.S. Energy Corp Stock Jumps as $285 Helium Deal Gives Big Sky a Buyer

U.S. Energy Corp. signed a five-year helium sales deal with an unnamed global industrial gas company, securing a buyer for output from its planned Big Sky Carbon Hub in Montana. The contract covers up to 1.2 million cubic feet a month at a fixed $285 per thousand cubic feet, with inflation adjustments starting March 2028. U.S. Energy shares rose 20.8% to $1.12 on heavy volume. The agreement is “take-or-pay,” with the buyer handling pickup at the plant.
27 April 2026
·

Stock Market Today

  • S&P 500 and Nasdaq Set for Intraday Records Amid Sector Strength and Earnings Focus
    April 27, 2026, 5:02 PM EDT. The S&P 500 and Nasdaq Composite are poised for their 12th and eighth intraday record highs of the year, respectively, driven by strong performances in semiconductors, mega-cap tech, and industrial sectors. Fresh highs emerged in multiple exchange-traded funds (ETFs) including small-cap tech, materials, and sectors like technology and semiconductors. Notable stocks hitting highs span various industries: Casey's in consumer staples; Kirby and Cummins in industrials; Nucor and Linde in materials; and big tech names like Alphabet, Nvidia, Intel, and Taiwan Semiconductor. The momentum continues despite recent concerns over the Strait of Hormuz closure and key May earnings reports. Investors remain focused on the resilience of mega-cap tech and cyclicals, underscoring a broad market advance across sectors and styles.

Latest article

Sagimet Stock Surges as $175 Million Raise Sharpens Acne Drug Push

Sagimet Stock Surges as $175 Million Raise Sharpens Acne Drug Push

27 April 2026
Sagimet Biosciences priced 29.17 million shares at $6 each, seeking to raise $175 million to fund a U.S. Phase 3 acne trial for denifanstat. Shares rose 38% to $8.12 on heavy volume Monday. The company will delay further work on its MASH liver-disease program unless it secures non-dilutive funding. Sagimet reported about $104.5 million in cash and equivalents.
Go toTop